Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Structure-activity relationship in pyrazolo[4,3-c]pyridines, first inhibitors of PEX14-PEX5 protein-protein interaction with trypanocidal activity
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4529792
Author(s) Dawidowski, Maciej; Kalel, Vishal C.; Napolitano, Valeria; Fino, Roberto; Schorpp, Kenji; Emmanouilidis, Leonidas; Lenhart, Dominik; Ostertag, Michael; Kaiser, Marcel; Kolonko, Marta; Tippler, Bettina; Schliebs, Wolfgang; Dubin, Grzegorz; Mäser, Pascal; Tetko, Igor V.; Hadian, Kamyar; Plettenburg, Oliver; Erdmann, Ralf; Sattler, Michael; Popowicz, Grzegorz M.
Author(s) at UniBasel Kaiser, Marcel
Mäser, Pascal
Year 2020
Title Structure-activity relationship in pyrazolo[4,3-c]pyridines, first inhibitors of PEX14-PEX5 protein-protein interaction with trypanocidal activity
Journal Journal of medicinal chemistry
Volume 63
Number 2
Pages / Article-Number 847-879
Abstract Trypanosoma; protists are pathogens leading to a spectrum of devastating infectious diseases. The range of available chemotherapeutics against; Trypanosoma; is limited, and the existing therapies are partially ineffective and cause serious adverse effects. Formation of the PEX14-PEX5 complex is essential for protein import into the parasites' glycosomes. This transport is critical for parasite metabolism and failure leads to mislocalization of glycosomal enzymes, with fatal consequences for the parasite. Hence, inhibiting the PEX14-PEX5 protein-protein interaction (PPI) is an attractive way to affect multiple metabolic pathways. Herein, we have used structure-guided computational screening and optimization to develop the first line of compounds that inhibit PEX14-PEX5 PPI. The optimization was driven by several X-ray structures, NMR binding data, and molecular dynamics simulations. Importantly, the developed compounds show significant cellular activity against; Trypanosoma; , including the human pathogen; Trypanosoma brucei gambiense; and; Trypanosoma cruzi; parasites.
Publisher American Chemical Society
ISSN/ISBN 0022-2623
edoc-URL https://edoc.unibas.ch/75603/
Full Text on edoc No
Digital Object Identifier DOI 10.1021/acs.jmedchem.9b01876
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/31860309
 
   

MCSS v5.8 PRO. 0.343 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
02/05/2024